PHARMACOKINETICS OF PEGYLATED LIPOSOMAL DOXORUBICIN: …
ウェブ Pegylated liposomal doxorubicin (doxorubicin HCl liposome injection; Doxil or Caelyx) is a liposomal formulation of doxorubicin, reducing uptake by the reticulo-endothelial … From pubmed.ncbi.nlm.nih.gov 作成者 Alberto Gabizon, Hilary Shmeeda, Yechezkel BarenholzPublish Year 2003
INFLUENCE OF DOSE AND ANIMAL SPECIES ON ACCELERATED …
ウェブ 2014年12月10日 The development of new PEGylated liposomal formulations containing anticancer drugs has shown that repeated-dose toxicity studies in two species (one … From sciencedirect.com 作成者 Takuya Suzuki, Masako Ichihara, Kenji Hyodo, Eiichi Yamamoto, Tatsuhiro Ishida, Hiroshi Kiwada, Hiro...Publish Year 2014
A PEGYLATED LIPOSOMAL PLATFORM: PHARMACOKINETICS ...
ウェブ the pegylated liposomal doxorubicin at a single dose of 10 mg/kg, no significant damage was observed in gastric, intestinal mucosa, and heart muscle, but pronounced … From jstage.jst.go.jp 作成者 Wan-Liang Lu, Xian-Rong Qi, Qiang Zhang, Rong-Yu Li, Gui-Lin Wang, Rui-Juan Zhang, Shu-Li WeiPublish Year 2004
PEGYLATED LIPOSOMAL DOXORUBICIN: OPTIMIZING THE DOSING ...
ウェブ 2005年3月1日 The maximum tolerated dose was pegylated liposomal doxorubicin 35 mg/m 2 plus gemcitabine 800 mg/m 2 every 21 days (pegylated liposomal doxorubicin dose intensity, 11.7 mg/m 2 per week), with febrile neutropenia and From theoncologist.onlinelibrary.wiley.com 作成者 Peter G. RosePublish Year 2005
THE EFFICACY AND CARDIAC TOXICITY OF DIFFERENT‐DOSE PEGYLATED ...
ウェブ 2022年10月6日 In order to explore the impact of pegylated liposomal doxorubicin (PLD) dose intensity on survival outcomes of newly diagnosed elderly patients with … From ncbi.nlm.nih.gov
FRONTIERS | A MULTICENTER RANDOMIZED TRIALS TO COMPARE THE ...
ウェブ 2022年11月24日 PurposeTo compare the pharmacokinetic (PK) bioequivalence (BE) and safety of a generic pegylated liposomal doxorubicin (PLD) formulation with the … From frontiersin.org
ウェブ 2021年11月19日 Here, we reported a kind of reduction-responsive PEGylated doxorubicin (DOX) prodrug via the simple esterification and amidation reactions, … From frontiersin.org
DOXORUBICIN, PEGYLATED LIPOSOMAL INTRAVENOUS: USES, SIDE ...
ウェブ Liposomal doxorubicin is an anthracycline-type chemotherapy drug that is used to treat certain types of cancer (such as ovarian cancer, AIDS-related Kaposi's sarcoma, … From webmd.com
ウェブ Decrease the dose of doxorubicin HCl in patients with elevated serum total bilirubin concentrations as follows: Serum bilirubin concentration Doxorubicin HCl Dose … From accessdata.fda.gov
SPECIFIC TARGETING OF PEGYLATED LIPOSOMAL DOXORUBICIN (DOXIL
ウェブ 2020年12月28日 Doxorubicin encapsulation in PEGylated liposomes (Doxil ®) has been shown to increase tumour localisation and decrease cardiotoxicity. From mdpi.com
PEGYLATED LIPOSOMAL DOXORUBICIN: A GUIDE TO ITS USE IN VARIOUS ...
ウェブ Pegylated liposomal doxorubicin (Caelyx(®) [EU], Doxil(®) [USA]) represents an improved formulation of conventional doxorubicin, with reduced cardiotoxicity and an … From pubmed.ncbi.nlm.nih.gov
PEGYLATED PLGA NANOPARTICLES FOR THE IMPROVED DELIVERY OF ...
ウェブ 2009年12月1日 Doxorubicin. PLGA. PEGylated. Nanoparticle. Drug delivery. The encapsulation of cytotoxic chemotherapeutic agents in biodegradable poly (lactic-co … From sciencedirect.com
HISTOLOGICAL EVIDENCE FOR THE CARDIAC SAFETY OF HIGH-DOSE ...
ウェブ 2019年10月15日 Pegylated liposomal doxorubicin plays an important role in the treatment of patients with severe refractory human immunodeficiency virus (HIV) … From bmcinfectdis.biomedcentral.com
PEGYLATED LIPOSOMAL DOXORUBICIN: OPTIMIZING THE DOSING ...
ウェブ Several phase II and retrospective studies support the use of pegylated liposomal doxorubicin 40 mg/m2 every 4 weeks (dose intensity of 10 mg/m2 weekly) to … From pubmed.ncbi.nlm.nih.gov
CARDIAC SAFETY ANALYSIS OF FIRST-LINE CHEMOTHERAPY DRUG ...
ウェブ 2022年8月16日 Strengths and limitations of pegylated liposomal doxorubicin in the treatment of ovarian cancer. The 2017 National comprehensive cancer network … From ovarianresearch.biomedcentral.com
PEGYLATED AND LIPOSOMAL DOXORUBICIN IS ASSOCIATED WITH …
ウェブ 2018年2月21日 7 Citations. Metrics. Abstract. Objective. We wanted to determine the impact of different doses of a pegylated and liposomal formulation of the cardiotoxic … From bmcresnotes.biomedcentral.com
PHASE I CLINICAL TRIAL OF PEGYLATED LIPOSOMAL DOXORUBICIN AND ...
ウェブ . Objective: The primary objective of this study was to determine the maximum tolerated dose (MTD) of pegylated liposomal doxorubicin (PLD) and docetaxel (T) … From pubmed.ncbi.nlm.nih.gov
DRUG NAME: DOXORUBICIN PEGYLATED LIPOSOMAL - BC CANCER
ウェブ Pegylated liposomal doxorubicin (PLD) is a formulation of doxorubicin in polyethylene glycol (PEG) coated Stealth® liposomes.3 “Pegylation” is the process whereby the … From bccancer.bc.ca
PEGYLATED LIPOSOMAL DOXORUBICIN: OPTIMIZING THE DOSING ...
ウェブ Several phase II and retrospective studies support the use of pegylated liposomal doxorubicin 40 mg/m2 every 4 weeks (dose intensity of 10 mg/m2 weekly) to … From theoncologist.onlinelibrary.wiley.com
PEGYLATED LIPOSOMAL DOXORUBICIN: METAMORPHOSIS OF AN OLD ...
ウェブ Drug Carriers. Drug Eruptions / etiology. Drug Hypersensitivity / etiology. Drug Synergism. Lethal Dose 50. Macrophages / metabolism. Maximum Tolerated Dose. Mononuclear … From pubmed.ncbi.nlm.nih.gov
Are you curently on diet or you just want to control your food's nutritions, ingredients? We will help you find recipes by cooking method, nutrition, ingredients...
